Recurrent hypoventilation and respiratory failure during gabapentin therapy.
Batoon
S B
SB
Vela
A T
AT
Dave
D
D
Wahid
Z
Z
Conetta
R
R
Iakovou
C
C
Banzuela
M
M
D000085:Acetates / Q000009:adverse effects*; D000368:Aged; D000588:Amines; D000700:Analgesics / Q000009:adverse effects*; D014151:Anti-Anxiety Agents / Q000009:adverse effects*; D000927:Anticonvulsants / Q000009:adverse effects*; D003509:Cyclohexanecarboxylic Acids; D000077206:Gabapentin; D006801:Humans; D007040:Hypoventilation / Q000139:chemically induced*; D008173:Lung Diseases, Obstructive / Q000188:drug therapy; D008297:Male; D010523:Peripheral Nervous System Diseases / Q000188:drug therapy; D012131:Respiratory Insufficiency / Q000139:chemically induced*; D005680:gamma-Aminobutyric Acid
D000085:Acetates; D000588:Amines; D000700:Analgesics; D014151:Anti-Anxiety Agents; D000927:Anticonvulsants; D003509:Cyclohexanecarboxylic Acids; D005680:gamma-Aminobutyric Acid; D000077206:Gabapentin